ARTES Biotechnology Launches New Website

ARTES Biotechnology GmbH, the leading provider of microbial cell line and process development for bio-pharmaceutical products is delighted to announce its website with new contents that is now live.

The new website follows ARTES’ extension in technology and especially features a section dedicated to the company’s recent growth and Metavax® approach for VLP-based vaccine development.

Dr. Melanie Piontek, ARTES’ Business Development Director comments, “Releasing the new content allows us to better show visitors what ARTES offers. The new website content clearly defines our products and services, particularly our recent technological developments.”

About ARTES Biotechnology
ARTES is a biotechnology company based in Germany, which focuses on recombinant protein production and process development in microbial expression systems. ARTES offers vaccine development, analytical assay development, fermentation and downstream process development and production cell line characterization. ARTES offers its services worldwide through its 850m2 S1 facilities in Langenfeld near Duesseldorf. ARTES concentrates on R&D services for white and red biotechnology products in addition to the development of innovative vaccine and diagnostic proteins.

For more information or to discuss ARTES Biotechnology launches new website please contact us directly.